Financhill
Buy
66

RDNT Quote, Financials, Valuation and Earnings

Last price:
$76.45
Seasonality move :
10.89%
Day range:
$77.53 - $81.08
52-week range:
$45.00 - $85.84
Dividend yield:
0%
P/E ratio:
1,513.25x
P/S ratio:
3.02x
P/B ratio:
5.73x
Volume:
789.7K
Avg. volume:
858.6K
1-year change:
-0.72%
Market cap:
$6.1B
Revenue:
$1.8B
EPS (TTM):
-$0.18

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
RDNT
RadNet, Inc.
$494M $0.23 8.08% 189.55% $91.71
CSTL
Castle Biosciences, Inc.
$71.1M -$0.51 -11.69% -26.99% $37.25
DCTH
Delcath Systems, Inc.
$25.3M -$0.09 32.37% -69.37% $22.31
ISPC
iSpecimen, Inc.
$2.9M -- 6.09% -- --
MEHCQ
Chrome Holding Co.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
RDNT
RadNet, Inc.
$78.59 $91.71 $6.1B 1,513.25x $0.00 0% 3.02x
CSTL
Castle Biosciences, Inc.
$38.64 $37.25 $1.1B 30.24x $0.00 0% 3.30x
DCTH
Delcath Systems, Inc.
$9.78 $22.31 $345.4M 1,124.14x $0.00 0% 4.66x
ISPC
iSpecimen, Inc.
$0.48 -- $4.7M -- $0.00 0% 0.42x
MEHCQ
Chrome Holding Co.
$3.50 -- $96.4M -- $0.00 0% 0.53x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
RDNT
RadNet, Inc.
63.58% 1.749 30.16% 1.77x
CSTL
Castle Biosciences, Inc.
7.37% 1.094 5.59% 6.09x
DCTH
Delcath Systems, Inc.
0.83% 1.825 0.25% 12.82x
ISPC
iSpecimen, Inc.
8.39% 3.626 2.23% 0.62x
MEHCQ
Chrome Holding Co.
-171.97% 10.446 19.84% 0.37x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
RDNT
RadNet, Inc.
$34.8M $34.8M 0.72% 1.82% 6.66% -$7.6M
CSTL
Castle Biosciences, Inc.
$61.5M -$6.8M -2.54% -2.71% -8.19% $7.8M
DCTH
Delcath Systems, Inc.
$17.9M -$388K 1.56% 1.59% -1.89% $4.3M
ISPC
iSpecimen, Inc.
-$555.7K -$2.8M -365.92% -430.7% -2654.97% -$3M
MEHCQ
Chrome Holding Co.
$9.5M -$30.7M -225.78% -453.89% -120.81% -$30M

RadNet, Inc. vs. Competitors

  • Which has Higher Returns RDNT or CSTL?

    Castle Biosciences, Inc. has a net margin of 2.66% compared to RadNet, Inc.'s net margin of -0.6%. RadNet, Inc.'s return on equity of 1.82% beat Castle Biosciences, Inc.'s return on equity of -2.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet, Inc.
    6.66% $0.07 $3.2B
    CSTL
    Castle Biosciences, Inc.
    74.09% -$0.02 $504.2M
  • What do Analysts Say About RDNT or CSTL?

    RadNet, Inc. has a consensus price target of $91.71, signalling upside risk potential of 16.7%. On the other hand Castle Biosciences, Inc. has an analysts' consensus of $37.25 which suggests that it could fall by -3.6%. Given that RadNet, Inc. has higher upside potential than Castle Biosciences, Inc., analysts believe RadNet, Inc. is more attractive than Castle Biosciences, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet, Inc.
    5 0 0
    CSTL
    Castle Biosciences, Inc.
    8 0 0
  • Is RDNT or CSTL More Risky?

    RadNet, Inc. has a beta of 1.485, which suggesting that the stock is 48.541% more volatile than S&P 500. In comparison Castle Biosciences, Inc. has a beta of 1.142, suggesting its more volatile than the S&P 500 by 14.213%.

  • Which is a Better Dividend Stock RDNT or CSTL?

    RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Castle Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. Castle Biosciences, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or CSTL?

    RadNet, Inc. quarterly revenues are $522.9M, which are larger than Castle Biosciences, Inc. quarterly revenues of $83M. RadNet, Inc.'s net income of $13.9M is higher than Castle Biosciences, Inc.'s net income of -$501K. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while Castle Biosciences, Inc.'s PE ratio is 30.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 3.02x versus 3.30x for Castle Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet, Inc.
    3.02x 1,513.25x $522.9M $13.9M
    CSTL
    Castle Biosciences, Inc.
    3.30x 30.24x $83M -$501K
  • Which has Higher Returns RDNT or DCTH?

    Delcath Systems, Inc. has a net margin of 2.66% compared to RadNet, Inc.'s net margin of 4.04%. RadNet, Inc.'s return on equity of 1.82% beat Delcath Systems, Inc.'s return on equity of 1.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet, Inc.
    6.66% $0.07 $3.2B
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
  • What do Analysts Say About RDNT or DCTH?

    RadNet, Inc. has a consensus price target of $91.71, signalling upside risk potential of 16.7%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 128.07%. Given that Delcath Systems, Inc. has higher upside potential than RadNet, Inc., analysts believe Delcath Systems, Inc. is more attractive than RadNet, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet, Inc.
    5 0 0
    DCTH
    Delcath Systems, Inc.
    5 0 0
  • Is RDNT or DCTH More Risky?

    RadNet, Inc. has a beta of 1.485, which suggesting that the stock is 48.541% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.

  • Which is a Better Dividend Stock RDNT or DCTH?

    RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or DCTH?

    RadNet, Inc. quarterly revenues are $522.9M, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. RadNet, Inc.'s net income of $13.9M is higher than Delcath Systems, Inc.'s net income of $830K. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while Delcath Systems, Inc.'s PE ratio is 1,124.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 3.02x versus 4.66x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet, Inc.
    3.02x 1,513.25x $522.9M $13.9M
    DCTH
    Delcath Systems, Inc.
    4.66x 1,124.14x $20.6M $830K
  • Which has Higher Returns RDNT or ISPC?

    iSpecimen, Inc. has a net margin of 2.66% compared to RadNet, Inc.'s net margin of -2608.44%. RadNet, Inc.'s return on equity of 1.82% beat iSpecimen, Inc.'s return on equity of -430.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet, Inc.
    6.66% $0.07 $3.2B
    ISPC
    iSpecimen, Inc.
    -521.3% -$0.48 $3.4M
  • What do Analysts Say About RDNT or ISPC?

    RadNet, Inc. has a consensus price target of $91.71, signalling upside risk potential of 16.7%. On the other hand iSpecimen, Inc. has an analysts' consensus of -- which suggests that it could grow by 12315.93%. Given that iSpecimen, Inc. has higher upside potential than RadNet, Inc., analysts believe iSpecimen, Inc. is more attractive than RadNet, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet, Inc.
    5 0 0
    ISPC
    iSpecimen, Inc.
    0 0 0
  • Is RDNT or ISPC More Risky?

    RadNet, Inc. has a beta of 1.485, which suggesting that the stock is 48.541% more volatile than S&P 500. In comparison iSpecimen, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock RDNT or ISPC?

    RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iSpecimen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. iSpecimen, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or ISPC?

    RadNet, Inc. quarterly revenues are $522.9M, which are larger than iSpecimen, Inc. quarterly revenues of $106.6K. RadNet, Inc.'s net income of $13.9M is higher than iSpecimen, Inc.'s net income of -$2.8M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while iSpecimen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 3.02x versus 0.42x for iSpecimen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet, Inc.
    3.02x 1,513.25x $522.9M $13.9M
    ISPC
    iSpecimen, Inc.
    0.42x -- $106.6K -$2.8M
  • Which has Higher Returns RDNT or MEHCQ?

    Chrome Holding Co. has a net margin of 2.66% compared to RadNet, Inc.'s net margin of -93.74%. RadNet, Inc.'s return on equity of 1.82% beat Chrome Holding Co.'s return on equity of -453.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet, Inc.
    6.66% $0.07 $3.2B
    MEHCQ
    Chrome Holding Co.
    37.22% -- -$15.8M
  • What do Analysts Say About RDNT or MEHCQ?

    RadNet, Inc. has a consensus price target of $91.71, signalling upside risk potential of 16.7%. On the other hand Chrome Holding Co. has an analysts' consensus of -- which suggests that it could fall by -40.57%. Given that RadNet, Inc. has higher upside potential than Chrome Holding Co., analysts believe RadNet, Inc. is more attractive than Chrome Holding Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet, Inc.
    5 0 0
    MEHCQ
    Chrome Holding Co.
    0 0 0
  • Is RDNT or MEHCQ More Risky?

    RadNet, Inc. has a beta of 1.485, which suggesting that the stock is 48.541% more volatile than S&P 500. In comparison Chrome Holding Co. has a beta of 2.154, suggesting its more volatile than the S&P 500 by 115.41%.

  • Which is a Better Dividend Stock RDNT or MEHCQ?

    RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chrome Holding Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. Chrome Holding Co. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or MEHCQ?

    RadNet, Inc. quarterly revenues are $522.9M, which are larger than Chrome Holding Co. quarterly revenues of $25.4M. RadNet, Inc.'s net income of $13.9M is higher than Chrome Holding Co.'s net income of -$23.8M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while Chrome Holding Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 3.02x versus 0.53x for Chrome Holding Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet, Inc.
    3.02x 1,513.25x $522.9M $13.9M
    MEHCQ
    Chrome Holding Co.
    0.53x -- $25.4M -$23.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 64.76% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.67% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 3.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock